These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37497120)

  • 1. Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study.
    Han YE; Jo J; Kim YJ; Lee J
    J Diabetes Res; 2023; 2023():1485059. PubMed ID: 37497120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of intravitreal ranibizumab and aflibercept for the treatment of diabetic macular edema: a real-world study.
    Isik P; Sizmaz S; Esen E; Uysal A; Demircan N
    Int Ophthalmol; 2023 Nov; 43(11):4171-4180. PubMed ID: 37505290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
    Debourdeau E; Medard R; Chamard C; Nguyen V; Gabrielle PH; Creuzot-Garcher C; Allieu S; Gillies MC; Barthelmes D; Daien V;
    Ophthalmol Ther; 2023 Oct; 12(5):2657-2670. PubMed ID: 37505396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Laser Photocoagulation in Treating Diabetic Macular Edema in the Era of Intravitreal Drug Administration: A Descriptive Review.
    Nozaki M; Ando R; Kimura T; Kato F; Yasukawa T
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512130
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravitreal Brolucizumab and Aflibercept for Polypoidal Choroidal Vasculopathy.
    Cho HJ; Kang KH; Yoon W; Lee J; Kim CG; Kim JW
    J Ocul Pharmacol Ther; 2023 Nov; 39(9):653-660. PubMed ID: 37504966
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of renal damage associated with intravitreal anti-VEGF therapy for diabetic macular edema in routine clinical practice.
    Del Cura Mar P; Carballés MJC; Sastre-Ibáñez M
    Indian J Ophthalmol; 2023 Aug; 71(8):3091-3094. PubMed ID: 37530286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual and Anatomical Outcomes After Initial Intravitreal Faricimab Injection for Neovascular Age-Related Macular Degeneration in Patients with Prior Treatment History.
    Inoda S; Takahashi H; Takahashi R; Hashimoto Y; Yoshida H; Takahashi H; Takayama T; Kawashima H; Yanagi Y
    Ophthalmol Ther; 2023 Oct; 12(5):2703-2712. PubMed ID: 37531030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration.
    Rush RB
    Clin Ophthalmol; 2023; 17():2201-2208. PubMed ID: 37547172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of anti-VEGF treatment for macular edema secondary to central retinal vein occlusion in patients with poor baseline visual acuity.
    Demir B; Mishra A; Gutierrez MPM; Rasheed R; Charitaki M; Preston E; Sivaprasad S; Hykin P; Nicholson L
    Can J Ophthalmol; 2024 Aug; 59(4):275-278. PubMed ID: 37517804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study.
    Mitchell P; Arnold J; Fraser-Bell S; Kang HK; Chang AA; Tainton J; Simonyi S
    BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37541745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment-A Meta-Analysis and Systematic Review.
    Garweg JG; Keiper J; Pfister IB; Schild C
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Neovascular Age-Related Macular Degeneration Treatment in France from 2008-2018: The Nationwide LANDSCAPE Study.
    Creuzot Garcher CP; Srour M; Baudin F; Dot C; Nghiem-Buffet S; Girmens JF; Collin C; Ponthieux A; Delcourt C
    Ophthalmol Ther; 2023 Oct; 12(5):2687-2701. PubMed ID: 37531029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention and Treatment of Retinal Vein Occlusion: The Role of Diet-A Review.
    Lendzioszek M; Mrugacz M; Bryl A; Poppe E; Zorena K
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Bevacizumab and Aflibercept for Suppression of Angiogenesis in Human Retinal Microvascular Endothelial Cells.
    Yazdanyar A; Cai CL; Aranda JV; Shrier E; Beharry KD
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review on the Safety and Efficacy of Brolucizumab for Neovascular Age-Related Macular Degeneration Erratum Major Studies and Real-World Data: Errata.
    Asia Pac J Ophthalmol (Phila); 2023 Jul-Aug 01; 12(4):422. PubMed ID: 37523440
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-Scg3 Gene Therapy to Treat Choroidal Neovascularization in Mice.
    Huang C; Ji L; Kaur A; Tian H; Waduge P; Webster KA; Li W
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration: The Phase 2 CANDELA Randomized Clinical Trial.
    Wykoff CC; Brown DM; Reed K; Berliner AJ; Gerstenblith AT; Breazna A; Abraham P; Fein JG; Chu KW; Clark WL; Leal S; Schmelter T; Hirshberg B; Yancopoulos GD; Vitti R;
    JAMA Ophthalmol; 2023 Sep; 141(9):834-842. PubMed ID: 37535382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Thickness Fluctuations in Eyes With Diabetic Macular Edema Treated With Intravitreal Steroid.
    Roan VD; Kuo BL; Liu BJ; Valentim CCS; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):454-460. PubMed ID: 37535650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between peripheral complete blood count parameters and diabetic macular edema in proliferative diabetic retinopathy patients: a cross-sectional study.
    Lei C; Gu J; Liu L; Zhang K; Zhang M
    Front Endocrinol (Lausanne); 2023; 14():1190239. PubMed ID: 37538792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study.
    Chatziralli I; Agapitou C; Dimitriou E; Kapsis P; Kazantzis D; Machairoudia G; Georgiadis O; Theodossiadis G; Theodossiadis P
    Semin Ophthalmol; 2024 Jan; 39(1):96-101. PubMed ID: 37539994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.